EMEA-001750-PIP01-15-M02

Key facts

Invented name
Juluca
Active substance
  • rilpivirine
  • dolutegravir
Therapeutic area
Infectious diseases
Decision number
P/0054/2019
PIP number
EMEA-001750-PIP01-15-M02
Pharmaceutical form(s)
  • Film-coated tablet
  • Age appropriate pharmaceutical form
Condition(s) / indication(s)
Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
ViiV Healthcare Limited

Tel.: +44 2089903650
E-mail: eu.paediatric-plans@gsk.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating